Clearmind Medicine Inc (CMND) Stock Price, Quote & News

Company Profile

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as...

Industry: Biotechnology

Sector: Healthcare

Phone: 973 536 1016

Website: www.clearmindmedicine.com

Address:

1220 West 6th Avenue, Suite 101, Vancouver, Canada

Jessedabesttt Sep. 2 at 9:54 PM

@MS_Tammy are you still holding $CMND or should we close the trade

0 · Reply

focafoca99 Sep. 2 at 8:21 PM

$CMND disclosed a conversion of $687.5K of promissory notes into common shares at $1 per share.

0 · Reply

RichJunkie25 Sep. 2 at 4:15 PM

$GP 🤣 You figured it out!!! NOT! No wonder you still chasing. NM PR dropped where is the 1-300% run up Scammy promised. LEARN! Next Tammy stock offers RUN after it jumps 10% after open. Otherwise, get ready to hold bags! $CMND $BJDX

1 · Reply

RichJunkie25 Sep. 1 at 7:06 PM

$CMND $GP $BJDX The latest Tammy casualties. Just remember it’s ok to follow Tammy but once that pumped stock is up 10% take the money and RUN! Do not hold. Do not hold out for larger gains. Take the quick small win and exit before you left holding the bag.

1 · Reply

undercoverbb Sep. 1 at 2:30 PM

$CMND is this a sell the news situation?

0 · Reply

YouVSYou Sep. 1 at 12:23 PM

$CMND 🟢 $1.98 breakout trigger 🔥 $2.11 break confirmation 🎯 $2.24/2.37 targets 🔴 $1.74 loss setup invalid 1.98 reclaim + volume key $BIAF Above $7.34: 🟢 GO / momentum confirmation $7.83: first profit-taking/resistance area $8.32: major upside target $6.84: critical hold Registered shares/warrants + selling = violent downside

0 · Reply

focafoca99 Sep. 1 at 12:13 PM

$CMND reached a key milestone as its CMND-100 Phase IIa trial for alcohol use disorder begins, with one-third of Part C enrolled.

0 · Reply